GSK (GSK)
NYSE: GSK
· Real-Time Price · USD
38.91
0.11 (0.28%)
At close: Aug 15, 2025, 11:58 AM
GSK Cash Flow Statement
Financials in GBP. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 3.86B | 3.39B | 2.66B | 2.51B | 4.1B | 4.67B | 5.26B | 6.54B | 5.78B | 4.38B | 4.92B | 4.23B | 4.82B | 6B | 5.1B | 5B | 5.07B | 5.97B |
Depreciation & Amortization | 3.35B | 2.83B | 2.55B | 3.32B | 2.94B | 2.76B | 2.85B | 1.68B | 2.06B | 2.23B | 2.3B | 2.8B | 2.83B | 2.87B | 2.52B | 2.96B | 2.62B | 791M |
Stock-Based Compensation | n/a | n/a | n/a | 307M | 307M | 307M | 307M | 346M | 346M | 346M | 346M | 343M | 343M | 343M | 343M | 393M | 393M | 393M |
Other Working Capital | 1.23B | 1.94B | 2.12B | 1.31B | 2.19B | 516M | 283M | -1.3B | -1.94B | 529M | 1.2B | 1.86B | 2.38B | 2.03B | 824M | -255M | -977M | 479M |
Other Non-Cash Items | -708M | -38M | 1.38B | 6.57B | 4.53B | 4.64B | 2.51B | -567M | -447M | -1.37B | 351M | -85M | -64M | 5M | -1.09B | -714M | -1.03B | -661M |
Deferred Income Tax | n/a | n/a | n/a | -865M | -865M | -865M | -865M | -784M | -784M | -784M | -784M | -1B | -1B | -1B | -1B | n/a | n/a | n/a |
Change in Working Capital | 1.23B | 1.61B | 2.09B | 144M | 1.02B | -327M | -856M | -1.73B | -2.36B | 102M | 271M | 2.32B | 2.92B | 1.29B | 1.42B | 784M | -316M | 1.71B |
Operating Cash Flow | 7.72B | 6.51B | 6.3B | 6.95B | 7B | 7.43B | 6.54B | 5.48B | 4.59B | 4.91B | 7.4B | 9.27B | 10.51B | 10.16B | 7.95B | 8.04B | 6.34B | 7.81B |
Capital Expenditures | -3.06B | -2.87B | -2.98B | -2.63B | -2.29B | -2.38B | -2.34B | -2.31B | -2.29B | -2.19B | -2.26B | -2.14B | -2.94B | -3.18B | -2.93B | -3.14B | -2.51B | -2.25B |
Cash Acquisitions | -975M | -972M | -867M | -773M | -829M | -1.34B | -669M | -673M | -3.59B | -3.12B | -3.14B | -3.16B | -210M | 200M | 185M | 217M | 309M | 2.67B |
Purchase of Investments | n/a | -32M | -50M | -81M | -114M | -85M | -123M | -114M | -144M | -155M | -144M | -138M | -99M | -105M | -42M | -41M | -206M | -368M |
Sales Maturities Of Investments | 57M | 1.3B | 2.38B | 3.4B | 3.41B | 2.97B | 1.91B | 883M | 925M | 127M | 116M | 122M | 32M | 435M | 497M | 625M | 864M | 3.29B |
Other Investing Acitivies | -1.39B | -1.06B | -924M | 311M | 817M | 137M | 331M | -187M | -905M | -255M | -3.4B | -3.33B | -2.52B | -2.34B | 889M | 1.26B | 1.08B | -1.17B |
Investing Cash Flow | -3.62B | -2.26B | -1.32B | 6M | 246M | -1.45B | -1.66B | -2.4B | -6.01B | -5.59B | -8.77B | -8.59B | -5.68B | -5.32B | -1.78B | -1.47B | -845M | 2.17B |
Debt Repayment | 740M | 1.07B | -1.17B | -4.18B | -4.68B | -3.1B | -2.37B | -6M | -113M | -3.96B | -4.42B | -5.43B | -4.51B | -2.04B | -2.04B | -1.14B | -3.74B | -3.94B |
Common Stock Repurchased | -808M | -247M | n/a | n/a | n/a | n/a | -2M | -2M | -2M | 2M | -3M | -3M | -3M | -7M | n/a | n/a | n/a | n/a |
Dividend Paid | -2.49B | -2.49B | -2.44B | -2.4B | -2.35B | -2.26B | -2.25B | -2.33B | -2.47B | -3.07B | -3.47B | -3.76B | -4.01B | -4B | -4B | -3.99B | -3.99B | -3.98B |
Other Financial Acitivies | -1.05B | -892M | -795M | -576M | -646M | -973M | -1.03B | -1.06B | -384M | -454M | 8.69B | 8.56B | 7.82B | 7.79B | -1.57B | -1.88B | -2.17B | -2.56B |
Financial Cash Flow | -3.6B | -2.54B | -4.38B | -6.85B | -7.37B | -6.03B | -5.36B | -3.39B | -2.95B | -7.47B | 823M | -613M | -681M | 1.76B | -7.59B | -6.99B | -9.87B | -10.46B |
Net Cash Flow | 445M | 1.54B | 550M | -66M | -233M | -88M | -646M | -332M | -4.39B | -8.03B | -392M | 160M | 4.23B | 6.62B | -1.44B | -462M | -4.48B | -594M |
Free Cash Flow | 4.67B | 3.64B | 3.32B | 4.32B | 4.72B | 5.05B | 4.2B | 3.17B | 2.29B | 2.73B | 5.14B | 7.13B | 7.56B | 6.99B | 5.02B | 4.9B | 3.83B | 5.56B |